3 Big Reasons You’re Getting Nothing Done at Work
Cell phones often get blamed for the always-on work culture that keeps us tethered to our jobs around the clock.
Turns out they might be the reason we’re not getting our work done during office hours in the first place. More than half of employers say that cell phones and texting are the biggest productivity killers at work, making them the number one distraction, according to a new survey from CareerBuilder.com.
Other top productivity killers included the Internet, named by 44 percent of employers, gossip (37 percent), and social media (37 percent).
Related: 10 Ways to Boost Happiness at Work
“There are so many stimulants in today’s workplace, it’s easy to see how employees get sidetracked,” Rosemary Haefner, Career Builder’s Chief Human Resources Officer said in a statement “The good news is, taking breaks from work throughout the day can actually be good for productivity, enabling the mind to take a break from the job at hand and re-energize you.”
Nearly half of employers said that such distractions compromised the quality of work, and 30 percent said they caused lower morale since other workers had to pick up slack for their preoccupied peers. A quarter of employers said that distractions hurt the boss/employee relationship.
Nearly 3 in 4 employers have been proactive about battling productivity killers, with a third blocking certain Internet sites and 23 percent banning personal cell phone calls and usage on the job.
Haefner recommends that workers stay focused by scheduling breaks, surrounding themselves with productive people and taking walks to rejuvenate the brain.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
